About UsUnderstanding AMLInterviewsGlobal NetworkGet InvolvedStoriesResources

What clinical trials look at molecular relapse?

Gail Roboz

November 11, 2020

During Blood Cancer Awareness Month, Know AML spoke to Gail Roboz, a world-leading doctor in acute myeloid leukemia who is based at Weill Cornell Medicine, New York, US. We asked, "Are there any clinical trials focusing on molecular relapses and treatment?" In this video, Gail describes what a molecular relapse is, and explains that although there are no specific drugs to target molecular relapse, there are ongoing trials into treating relapse in specific molecular diseases such as NMP1-mutated and core binding factor AML.